Goldman Sachs reports sale of 105,807 Attovia Therapeutics shares worth $2.22 million
ATTO•Goldman Sachs trading activity in Attovia Therapeutics
Goldman Sachs reported trading activity in Attovia Therapeutics common stock on Aug. 5, 2026.
- Purchased 85,000 shares at USD 21.
- Sold 105,807 shares at prices from USD 20.84 to USD 22.11.
- Reported holdings from that activity fell to zero by end of Aug. 5.
- On Aug. 6, it acquired 2.44 million shares via preferred-stock conversions, lifting beneficial ownership to 3.02 million shares.
